Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$14.79
-7.7%
$26.77
$13.74
▼
$40.99
$3.47B2.5322.07 million shs8.39 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,353.70
+0.2%
$1,263.45
$850.51
▼
$1,475.25
$1.27T0.42.95 million shs1.46 million shs
MSCI Inc stock logo
MSCI
MSCI
$624.53
+0.0%
$590.88
$501.08
▼
$681.04
$44.64B1.2632,439 shs243,054 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-6.42%-18.92%-45.05%-52.42%-55.26%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-2.08%-5.66%+5.18%+7.55%+28.91%
MSCI Inc stock logo
MSCI
MSCI
-1.77%-4.24%+5.30%+10.71%+11.57%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$14.79
-7.7%
$26.77
$13.74
▼
$40.99
$3.47B2.5322.07 million shs8.39 million shs
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,353.70
+0.2%
$1,263.45
$850.51
▼
$1,475.25
$1.27T0.42.95 million shs1.46 million shs
MSCI Inc stock logo
MSCI
MSCI
$624.53
+0.0%
$590.88
$501.08
▼
$681.04
$44.64B1.2632,439 shs243,054 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-6.42%-18.92%-45.05%-52.42%-55.26%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
-2.08%-5.66%+5.18%+7.55%+28.91%
MSCI Inc stock logo
MSCI
MSCI
-1.77%-4.24%+5.30%+10.71%+11.57%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.13
Hold$30.80106.75% Upside
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.83
Moderate Buy$1,422.005.21% Upside
MSCI Inc stock logo
MSCI
MSCI
2.94
Moderate Buy$683.699.47% Upside

Current Analyst Ratings Breakdown

Latest MSCI, LLY, and HIMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/20/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetNeutral$26.00 ➝ $21.00
11/17/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Reiterated RatingOutperform$1,600.00
11/16/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetOverweight$1,400.00 ➝ $1,550.00
11/13/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
UpgradeBuy (B) ➝ Buy (B+)
11/12/2026
MSCI Inc stock logo
MSCI
MSCI
UpgradeBuy (B-) ➝ Buy (B)
11/12/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
DowngradeBuy ➝ Hold
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetHold$31.00 ➝ $24.00
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetEqual Weight$28.00 ➝ $25.00
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetBuy$42.00 ➝ $32.00
11/9/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Boost Price TargetBuy$1,610.00 ➝ $1,700.00
11/4/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Reiterated RatingSell (D)
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.35B1.49$0.73 per share20.37$1.52 per share9.80
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$65.18B19.51$24.57 per share55.01$42.81 per share31.57
MSCI Inc stock logo
MSCI
MSCI
$3.13B14.25$20.67 per share30.21($42.19) per share-14.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.83N/AN/AN/A-6.65%-9.62%-1.38%N/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$20.64B$30.8143.8726.651.6531.90%86.76%22.03%2/3/2027 (Estimated)
MSCI Inc stock logo
MSCI
MSCI
$1.20B$18.8933.0927.992.5240.31%-50.69%25.15%1/26/2027 (Estimated)

Latest MSCI, LLY, and HIMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.0563$0.0280-$0.0283-$0.14$893.13 million$890.37 million
10/29/2026Q3 2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$5.71$7.48+$1.77$7.22$22.58 billion$24.40 billion
10/20/2026Q3 2026
MSCI Inc stock logo
MSCI
MSCI
$5.03$5.11+$0.08$4.86$887.83 million$892.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.920.51%+15.18%22.46%11 Years
MSCI Inc stock logo
MSCI
MSCI
$8.201.31%+19.78%43.41%11 Years

Latest MSCI, LLY, and HIMS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/26/2026
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.730.48%11/13/202611/13/202612/10/2026
10/19/2026
MSCI Inc stock logo
MSCI
MSCI
quarterly$2.051.25%11/13/202611/13/202611/27/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
3.85
0.92
0.84
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1.17
1.39
1.00
MSCI Inc stock logo
MSCI
MSCI
N/A
0.82
0.82

Institutional Ownership

CompanyInstitutional Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
MSCI Inc stock logo
MSCI
MSCI
89.97%

Insider Ownership

CompanyInsider Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
MSCI Inc stock logo
MSCI
MSCI
3.76%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442234.41 million206.85 millionOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
50,000940.74 million939.43 millionOptionable
MSCI Inc stock logo
MSCI
MSCI
6,26871.50 million68.81 millionOptionable

Recent News About These Companies

Global Market Today: Asian stocks slide as AI fears trigger selloff
Sands China Departing MSCI Hong Kong Index
MSCI Inc (MSCI) - What Are Researchers Saying About This Stock?
NationGate to join MSCI Index as seven removed
MSCI rejig: Which stocks may see the biggest inflows & outflows?
Taiwan weighting in three major indices raised: MSCI

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$14.87 -1.15 (-7.19%)
As of 01:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$1,353.96 +2.84 (+0.21%)
As of 01:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

MSCI stock logo

MSCI NYSE:MSCI

$624.63 +0.30 (+0.05%)
As of 01:17 PM Eastern
This is a fair market value price provided by Massive. Learn more.

MSCI Inc., together with its subsidiaries, provides critical decision support tools and solutions for the investment community to manage investment processes worldwide. The Index segment provides indexes for use in various areas of the investment process, including indexed financial product, such as ETFs, mutual funds, annuities, futures, options, structured products, and over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, application, an integrated view of risk and return service, and an analysis of market, credit, liquidity, counterparty, and climate risk across asset classes; managed services, including consolidation of client portfolio data, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The ESG and Climate segment provides products and services that help institutional investors understand how ESG impacts the long-term risk and return of their portfolio and individual security-level investments; and data, ratings, research, and tools to help investors navigate increasing regulation. The All Other Private Assets segment includes real estate and infrastructure data, benchmarks, return-analytics, climate assessments and market insights; business intelligence to real estate owners, managers, developers, and brokers; and offers investment decision support tools for private capital. The Private Capital Solutions segment offers tools to help private asset investors across mission-critical workflows, such as sourcing terms and conditions, evaluating operating performance, managing risk and other activities supporting private capital investing. MSCI Inc. was incorporated in 1998 and is headquartered in New York, New York.